{"disease":{"id":"cirrhosis","name":"cirrhosis"},"drugs":{"marketed":[{"drug_id":"seladelpar","indication_name":"decompensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Livdelzi","generic_name":"SELADELPAR","company_name":"Gilead Sciences Inc","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":64,"revenue":"200","mechanism":"Livdelzi works by inhibiting the activity of a specific enzyme involved in the progression of liver disease."},{"drug_id":"potassium-bicarbonate","indication_name":"Prevention of Potassium Depletion - Hepatic Cirrhosis with Ascites","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"POTASSIUM BICARBONATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":14,"revenue":null,"mechanism":null},{"drug_id":"ethacrynic-acid","indication_name":"Edema in Cirrhosis of the Liver","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Edecrin","generic_name":"ETHACRYNIC ACID","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glutathione S-transferase P","drug_class":"Loop Diuretic [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"sovaldi","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sovaldi","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cereblon isoform 4, Genome polyprotein, NS5","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"sovaldi","indication_name":"Decompensated cirrhosis of liver","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Sovaldi","company_name":"Genuine Research Center, Egypt","drug_phase":"marketed","molecular_target":"Cereblon isoform 4, Genome polyprotein, NS5","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"spironolacton","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Spironolacton","company_name":"ACS Biomarker","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"chlorothiazide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diuril","generic_name":"CHLOROTHIAZIDE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"frusemide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Frusemide","company_name":"Melbourne Health","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"torasemide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Torasemide","company_name":"Medical University of Warsaw","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ursolvan","indication_name":"Primary biliary cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ursolvan","company_name":"Hopital Foch","drug_phase":"phase_3","molecular_target":"Aldo-keto reductase family 1 member C2, CDGSH iron-sulfur domain-containing protein 1, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"hydrochlorothiazide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Microzide","generic_name":"hydrochlorothiazide","company_name":"Generic (originally Merck)","drug_phase":"marketed","molecular_target":"ACE","drug_class":"Thiazide Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Lisinopril inhibits ACE, reducing angiotensin II and aldosterone, leading to lower blood pressure."},{"drug_id":"spironolactone","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aldactone","generic_name":"spironolactone","company_name":"Generic (originally Searle/Pfizer)","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"Aldosterone Antagonist [EPC]","quality_score":56,"revenue":null,"mechanism":"Potassium-sparing diuretic and mineralocorticoid receptor antagonist that blocks aldosterone, reducing fluid retention and lowering blood pressure."},{"drug_id":"elafibranor","indication_name":"Decompensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Iqirvo","generic_name":"ELAFIBRANOR","company_name":"Ipsen","drug_phase":"marketed","molecular_target":"","drug_class":"Peroxisome Proliferator-activated Receptor Agonist [EPC]","quality_score":60,"revenue":null,"mechanism":"Iqirvo works by activating peroxisome proliferator-activated receptors to improve liver function."},{"drug_id":"bumetanide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bumex","generic_name":"BUMETANIDE","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"Loop Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"glecaprevir","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mavyret","generic_name":"GLECAPREVIR","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"","drug_class":"Hepatitis C Virus NS5A Inhibitor [EPC]","quality_score":70,"revenue":null,"mechanism":"Mavyret works by blocking the NS3/4A protease enzyme, preventing the hepatitis C virus from replicating."},{"drug_id":"ursodiol","indication_name":"Primary biliary cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Actigall","generic_name":"URSODIOL","company_name":"AbbVie","drug_phase":"marketed","molecular_target":"CDGSH iron-sulfur domain-containing protein 1","drug_class":"Bile Acid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"furosemide","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lasix","generic_name":"furosemide","company_name":"Generic (originally Hoechst AG)","drug_phase":"marketed","molecular_target":"ATP-binding cassette sub-family G member 2, CDGSH iron-sulfur domain-containing protein 1, G-protein coupled receptor 35","drug_class":"Loop Diuretic [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"chlorthalidone","indication_name":"Edema associated with hepatic cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CHLORTHALIDONE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/Cl− cotransporter","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"ribavarin","indication_name":"Compensated cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ribavarin","company_name":"Charles University, Czech Republic","drug_phase":"discontinued","molecular_target":"Cytosolic purine 5'-nucleotidase, Adenosine kinase, Ectonucleotide pyrophosphatase/phosphodiesterase family member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"chlorothiazide","indication_name":"Edema in Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diuril","generic_name":"CHLOROTHIAZIDE","company_name":"Salix Pharms","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"spirolactone","indication_name":"Edema due to Hepatic Cirrhosis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"spirolactone","company_name":"Second Xiangya Hospital of Central South University","drug_phase":"phase_1","molecular_target":"Cytochrome P450 2C19, Multidrug and toxin extrusion protein 1, Nuclear receptor subfamily 1 group I member 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":21,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05744713","title":"An Observational Study of Patients With Chronic Liver Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":500000,"lead_sponsor_name":"Target PharmaSolutions, Inc.","has_results":false},{"nct_id":"NCT06458998","title":"Getting To Implementation: Improving Cancer Screening for Veterans","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30300,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT07241195","title":"A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"The Affiliated Hospital of Hangzhou Normal University","has_results":false},{"nct_id":"NCT06248580","title":"Find HDV and Determine Its Status in Turkey","phase":"","overall_status":"RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Yaşar Bayındır, MD","has_results":false},{"nct_id":"NCT06338215","title":"Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality","phase":"NA","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT03267615","title":"VICIS - Vienna Cirrhosis Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT05140837","title":"Early Diagnosis and Timely Treatment of Cirrhotic Patients With Minimal Hepatic Encephalopathy (CHESS-NCRCID 2106)","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Hepatopancreatobiliary Surgery Institute of Gansu Province","has_results":false},{"nct_id":"NCT06061328","title":"Project OASIS: Optimizing Approaches to Select Implementation Strategies","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":8020,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05094869","title":"Prevention of HCC Using Mobile Phone Applications","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06977685","title":"Effect of Non-Selective Beta-Blockers on Outcomes in Cirrhosis Patients After Hospitalization: A Retrospective Cohort Using Target Trial Design","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":7725,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT05360420","title":"Diagnosis of Nodules ≤2 cm Based on US and CEUS Compared With Current Clinical Procedure","phase":"NA","overall_status":"UNKNOWN","enrollment_count":6730,"lead_sponsor_name":"Tianjin Third Central Hospital","has_results":false},{"nct_id":"NCT07160946","title":"Risk Assessment for HBV-Related Liver Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06084234","title":"National Liver Cancer Screening Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":5500,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05463796","title":"InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04371042","title":"PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05486572","title":"Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI","phase":"NA","overall_status":"RECRUITING","enrollment_count":4700,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT04160897","title":"Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Qing XIe","has_results":false},{"nct_id":"NCT07070362","title":"Digital Early Warning System for Acute Lung Injury in Liver Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"Beijing Tsinghua Chang Gung Hospital","has_results":false},{"nct_id":"NCT04149223","title":"Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":3975,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT04957875","title":"Timing of Endoscopy for Acute Variceal Bleeding in Patients With Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":3300,"lead_sponsor_name":"Hepatopancreatobiliary Surgery Institute of Gansu Province","has_results":false},{"nct_id":"NCT04613921","title":"Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"European Foundation for Study of Chronic Liver Failure","has_results":false},{"nct_id":"NCT06519162","title":"Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Chungnam National University Hospital","has_results":false},{"nct_id":"NCT06544863","title":"Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05786755","title":"Compositional Shift of Gut Microbiome According to the Complications in Patients With Liver Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Chuncheon Sacred Heart Hospital","has_results":false},{"nct_id":"NCT03228095","title":"Volatiles in Breath and Headspace Analysis - Diagnostic Markers","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"University of Latvia","has_results":false},{"nct_id":"NCT07249112","title":"DEFINITION OF THE GENOMIC LANDSCAPE OF MASLD","phase":"NA","overall_status":"RECRUITING","enrollment_count":2880,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT04281784","title":"Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2512,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT06392503","title":"Noninvasive Diagnosis Model for High-risk Varices in Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Beijing 302 Hospital","has_results":false},{"nct_id":"NCT06741904","title":"Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2334,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT07438288","title":"Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis","phase":"","overall_status":"RECRUITING","enrollment_count":2200,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT03775798","title":"Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.","phase":"","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Austral University, Argentina","has_results":false},{"nct_id":"NCT04794946","title":"Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver Cirrhosis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07319299","title":"STOP HCC-GAAD-APAC-Thailand","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":2100,"lead_sponsor_name":"Mahidol University","has_results":false},{"nct_id":"NCT07298577","title":"Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2100,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT05473325","title":"Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Willows Health","has_results":false},{"nct_id":"NCT05782556","title":"Freiburg TIPS Registry","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University Hospital Freiburg","has_results":false},{"nct_id":"NCT05513651","title":"Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT07216859","title":"Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT04767945","title":"Cirrhosis Registry of Hospitalized Patients","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica","has_results":false},{"nct_id":"NCT05719480","title":"A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT05457114","title":"Association Between the Use of Pulmonary Artery Catheter and Clinical Outcomes After Liver Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":1970,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT03694600","title":"Clinical Trial Multi-analyte Blood Test","phase":"","overall_status":"UNKNOWN","enrollment_count":1900,"lead_sponsor_name":"Helio Genomics","has_results":false},{"nct_id":"NCT00913757","title":"A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area","phase":"","overall_status":"COMPLETED","enrollment_count":1871,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03723317","title":"Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival","phase":"","overall_status":"COMPLETED","enrollment_count":1782,"lead_sponsor_name":"European Hepatocellular Cancer Liver Transplant Group","has_results":false},{"nct_id":"NCT05641025","title":"Prediction of Multidrug-resistant Bacterial Infection in Patients with Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":1774,"lead_sponsor_name":"Hospital Italiano de Buenos Aires","has_results":false},{"nct_id":"NCT03846180","title":"Terlipressin on Effect of Renal Function in Cirrhotic Patients With Acute Gastrointestinal Hemorrhage","phase":"","overall_status":"COMPLETED","enrollment_count":1682,"lead_sponsor_name":"General Hospital of Shenyang Military Region","has_results":false},{"nct_id":"NCT07465003","title":"Cohort Study of Chronic Liver Disease Complicated by Sepsis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"The Second Affiliated Hospital of Chongqing Medical University","has_results":false},{"nct_id":"NCT07473375","title":"Indicators Affecting PVT Recanalization","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06181448","title":"Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT03342170","title":"Influence of ABO Blood Group on the Risk of Complications in Alcoholic or Viral C Cirrhosis?","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"University Hospital, Caen","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}